ConductScience.org, home

Paper3294124

Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial.

Galmiche JP and 9 others. Gut, 1988. Cited by 95 papers, by iCite.

Cite this record

ConductScience Library. Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial. Papers, record 3294124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3294124

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial.
PubMed
Journal
Gut
PubMed
Year
1988
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
95
iCite
Relative citation ratio, by iCite
6.08
iCite
Revised in PubMed
2019-05-01
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Galmiche JPJ P
2Brandstätter GG
3Evreux MM
4Hentschel EE
5Kerstan EE
6Kratochvil PP
7Reichel WW
8Schütze KK
9Soule JCJ C
10Vitaux JJ

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CimetidineMajor topic
Esophagitis, PepticMajor topic
PiperidinesMajor topic
Adult
Aged
Cisapride
Clinical Trials as Topic
Double-Blind Method
Drug Combinations
Esophagoscopy
Female
Heartburn
Humans
Male
Middle Aged
Random Allocation

Source PubMed

Download CSV of topics

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16311693Treatment of reflux oesophagitis with ranitidine.Gut1983https://conductscience.org/library/papers/6311693PubMed
26092288Ranitidine, cimetidine, antacids, and gastro-oesophageal reflux: results of a 20-hour oesophageal pH study.Int J Clin Pharmacol Res1984https://conductscience.org/library/papers/6092288PubMed
33884468Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride).Gut1985https://conductscience.org/library/papers/3884468PubMed
42866742Medical therapy for reflux esophagitis: 1986 and beyond.Ann Intern Med1986https://conductscience.org/library/papers/2866742PubMed
53940501Treatment of severe reflux esophagitis with cimetidine and metoclopramide.Ann Intern Med1986https://conductscience.org/library/papers/3940501PubMed
63518407Chronic oral treatment with cisapride decreases high bile salt reflux rates.Am J Gastroenterol1986https://conductscience.org/library/papers/3518407PubMed
76407606Cimetidine and metoclopramide in oesophageal reflux disease.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6407606PubMed
813747Patterns of gastroesophageal reflux in health and disease.Ann Surg1976https://conductscience.org/library/papers/13747PubMed
9340333Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial.Gastroenterology1978https://conductscience.org/library/papers/340333PubMed
10346430Oral cimetidine in reflux esophagitis: a double blind controlled trial.Gastroenterology1978https://conductscience.org/library/papers/346430PubMed
117000475Controlled trial of cimetidine in reflux esophagitis.Dig Dis Sci1980https://conductscience.org/library/papers/7000475PubMed
127004292Reflux esophagitis: effect of oral bethanechol on symptoms and endoscopic findings.Ann Intern Med1980https://conductscience.org/library/papers/7004292PubMed
137016659Pathogenesis of reflux esophagitis.Gastroenterology1981https://conductscience.org/library/papers/7016659PubMed
14319356A controlled trial of metoclopramide in symptomatic gastroesophageal reflux.N Engl J Med1977https://conductscience.org/library/papers/319356PubMed

Download CSV of references

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 95 citations.

PMIDTitleJournalYearIn PapersSource
29606884Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions.Clin Exp Gastroenterol2018https://conductscience.org/library/papers/29606884PubMed
27075264Management of refractory typical GERD symptoms.Nat Rev Gastroenterol Hepatol2016https://conductscience.org/library/papers/27075264PubMed
22523727Effects of Rikkunshito (TJ-43) on Esophageal Motor Function and Gastroesophageal Reflux.J Neurogastroenterol Motil2012https://conductscience.org/library/papers/22523727PubMed
21673949Prokinetic drug utility in the treatment of gastroesophageal reflux esophagitis: a systematic review of randomized controlled trials.Open Med2007https://conductscience.org/library/papers/21673949PubMed
18370513Meta-Analyses of Cisapride, Omeprazole and Ranitidine in the Treatment of GORD: Implications for Treating Patient Subgroups.Clin Drug Investig1998https://conductscience.org/library/papers/18370513PubMed
16015691Effect of itopride, a new prokinetic, in patients with mild GERD: a pilot study.World J Gastroenterol2005https://conductscience.org/library/papers/16015691PubMed
15345875Management of unresponsive asthma.Indian J Pediatr2004https://conductscience.org/library/papers/15345875PubMed
15082617A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials.Gut2004https://conductscience.org/library/papers/15082617PubMed
12749748Medical management of nocturnal symptoms of gastro-oesophageal reflux disease in the elderly.Drugs Aging2003https://conductscience.org/library/papers/12749748PubMed
11096564Noncardiac Chest Pain of Esophageal Origin.Curr Treat Options Gastroenterol1998https://conductscience.org/library/papers/11096564PubMed
10870511An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.CMAJ2000https://conductscience.org/library/papers/10870511PubMed
10741335An evidence-based appraisal of reflux disease management--the Genval Workshop Report.Gut1999https://conductscience.org/library/papers/10741335PubMed
10724795Economic evaluation of long-term management strategies for erosive oesophagitis.Pharmacoeconomics1999https://conductscience.org/library/papers/10724795PubMed
8879971Cisapride. Drug interactions of clinical significance.Drug Saf1996https://conductscience.org/library/papers/8879971PubMed
8527013A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders.Drug Saf1995https://conductscience.org/library/papers/8527013PubMed
7601011Pharmacological management of gastro-oesophageal reflux disease.Drugs1995https://conductscience.org/library/papers/7601011PubMed
7510617Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.Drugs1994https://conductscience.org/library/papers/7510617PubMed
3065057Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders.Drugs1988https://conductscience.org/library/papers/3065057PubMed
2680794Effect of cisapride on postprandial gastro-oesophageal reflux.Gut1989https://conductscience.org/library/papers/2680794PubMed
2573565Histamine-2-receptor antagonists in gastro-oesophageal reflux.Gut1989https://conductscience.org/library/papers/2573565PubMed

See all 26 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3294124

GET https://conductscience.org/api/papers/v1/3294124/cited_by?page=2